Are you Dr. Lestini?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34th & Civic Center Blvd
Children's Hospital Of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-2204- Is this information wrong?
Summary
- Dr. Brian Lestini, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital Los AngelesResidency, Pediatrics, 2003 - 2006
Case Western Reserve University School of MedicineClass of 2003
Certifications & Licensure
PA State Medical License 2006 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 132 citationsResistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway ActivationFei Su, William D. Bradley, Qiongqing Wang, Hong Yang, Lizhong Xu, Brian Higgins, Kenneth Kolinsky, Packman Kathryn E, Min Jung Kim, Kerstin Trunzer, Richard T. Lee, K...> ;Cancer Research. 2012 Feb 15
- 168 citationsAntitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal CancerHong Yang, Brian Higgins, Kenneth Kolinsky, Packman Kathryn E, William D. Bradley, Richard J. Lee, Kathleen Schostack, Mary Simcox, Scott Kopetz, David C. Heimbrook, B...> ;Cancer Research. 2012 Feb 1
- 749 citationsRAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.Fei Su, Amaya Viros, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis-Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chap...> ;The New England Journal of Medicine. 2012 Jan 18
- Join now to see all
Press Mentions
- Pyramid Biosciences Receives Orphan Drug Designation for PBI-200 from FDAJuly 6th, 2022
Novavax CFO Greg Covino Makes a Quick Exit as Leadership Carousel Keeps Turning; Kite Execs Fly Away to a Cell Therapy Upstart Teaming up with LyellApril 16th, 2021
